All In Biotech

Drug Trial Radar · NCT07687966

CBP-0276 to Reduce Opioid Use in Adults Undergoing Major Orthopedic Surgery

Proof-of-concept, Double-blind, Randomized Clinical Study to Evaluate the Safety and Efficacy of CBP-0276 at Doses of 600 mg/Day vs Placebo in Reducing Opioid Use in Pain Management in Adult Patients Undergoing Major Orthopedic Surgery

Last checked: Nov 19, 2026Latest source record: Jul 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

80

Planned (sponsor's estimate)

Start

May 8, 2026

Primary completion

Jun 30, 2026

Study completion Sep 30, 2026

Sponsor

Lead sponsor
Clarent Biopharma, Inc.Industry
Sponsor type
Industry
First posted
Jul 7, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 40 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Randomized, double-blind, clinical study to evaluate the safety and efficacy of CBP-0276 at doses of 600 mg/day in reducing opioid use in pain management in adult patients undergoing major orthopedic surgery. Subjects will be allocated in 2 groups. One group will receive oxycodone (standard of care) + CBP-0276 at a dose of 600 mg, orally once daily for 28 days. A second group will receive oxycodone (standard of care) + placebo for CBP-0276, orally once daily for 28 days

Conditions

  • Hip or Knee Replacement

Interventions

  • CBP-0276Drug

    Oxycodone CBP-0276 orally 600mg QD, orally once a day for 30 days

  • Placebo for CBP-0276Drug

    Oxycodone (standard of care) + placebo for CBP-0276, orally once daily for 30 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Frequency of oxycodone useTime frame: 28 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Innovacion y Desarrollo de Estrategias en Salud

    Mexico City, Mexico · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.